// App-Quantinova.ai

1474 : IL‐6 and Ykl‐40 in severe asthma

Researchers

Presenter

  • Castro MCE

Principal Investigators

  • Lockett G

  • Lau L

  • Barber C

  • Elliott S

  • Brown T

  • Chauhan A

  • Holloway J

  • Howarth P

Medical Centers

  • CHLN‐HSM‐ ImmunoAllergy, Lisbon, Portugal

  • Lisbon Medical School – Lisbon

  • Universidade de Lisboa, Lisbon, Portugal

  • Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • Clinical & Experimental Sciences, Faculty of Medicine, University of Southampton—Southampton, Southampton, United Kingdom

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

  • Southampton NIHR Respiratory Biomedical Research Unit ‐Southampton, Southampton, United Kingdom

Locations

  • Portugal

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A